Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Adenocarcinoma of Lung 2Uterine Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Radiomics 1Prostatic Neoplasms 1Pituitary Diseases 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neuroendocrine Tumors 1Lung Neoplasms 1Lung Diseases 1Liver Cirrhosis 1Hepatitis B 1Head and Neck Neoplasms 1Disease Progression 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Lobular 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Radiomics × Clear all
NCT03917017 2022-02-15

The Evaluation of Surgical Decisions and Prognosis of the Radiomics and Watson Artificial Intelligence in Patients With Hepatocellular Carcinoma

Zhujiang Hospital

Phase NA Unknown
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03221049 2021-09-02

Radiomics for Diagnosing Liver Diseases and Evaluating Progression

Third Affiliated Hospital, Sun Yat-Sen University

Unknown
3,000 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Liver Cirrhosis, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡